Provider
Self-Administered Oncology Agents - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jul 01, 2026
Documents & Forms Results
Displaying 3641 - 3650 of 3704 results
Provider
Spevigo (spesolimab-sbzo) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jul 01, 2026
Provider
Subcutaneous Furosemide - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jul 01, 2026
Provider
Sunosi (solriamfetol) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jul 01, 2026
Provider
Otezla (apremilast) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jul 01, 2026
Provider
Oxybate - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jul 01, 2026
Provider
Cardiac Myosin Inhibitors - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jul 01, 2026
Provider
Dry Eye Disease - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jul 01, 2026
Provider
Glucose Test Strips and Meters - Commercial
Quantity Limit
Program effective Date: Jul 01, 2026
Provider
GLP-1 (glucagon-like peptide-1) Agonists - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jul 01, 2026